Nasus Pharma Files for $11 Million U.S. IPO to Advance Intranasal Allergy Treatment
TEL AVIV, July 9, 2025 – Israeli biotech firm Nasus Pharma, a clinical-stage company developing intranasal powder therapies for life-threatening allergic reactions, has filed for an $11...
Chenghe Acquisition III Co. Eyes Asian Growth with $126.5 Million SPAC Offering
Targeting Asia’s Growth Through a Strategic SPAC Launch
Chenghe Acquisition III Co. (NASDAQ: CHECU), a blank check company incorporated in the Cayman Islands, has officially...
Company Spotlight: Emmis Acquisition Corp. Targets Strategic Business Combination through $115 Million SPAC IPO
Emmis Acquisition Corp., a newly formed blank-check company incorporated as a Cayman Islands exempted entity, has filed to go public on the NASDAQ Capital Market under...
Empro Group Inc. (EMPG) IPO: Singaporean Aerospace Integrator Lands on Nasdaq Capital
On July 15, 2025, Empro Group Inc.—a Singapore-based company specializing in aerospace parts manufacturing, MRO (maintenance, repair and overhaul), and related engineering services—priced its IPO...
Robot Consulting Co., Ltd. (LAWR) IPO: Singapore Robotics Innovator Begins Nasdaq Journey
On July 15, 2025, Robot Consulting Co., Ltd.—a Singapore-based robotics solutions and automation services provider—made its debut on the Nasdaq Capital Market under the ticker LAWR. The company...
